Filing Flows

Filing Flows › Standard Biotools (LAB) › Who owns the stock

Who owns Standard Biotools (LAB) stock

135 funds reported Standard Biotools (LAB) shares in their latest 13F filings, worth $265M in all. The largest holder is Casdin Capital, LLC ($73.0M). Last quarter 80 funds added to their stakes and 80 cut them.

Largest holders of LAB (13F)Largest holders of LAB (13F)Casdin Capital, LLC$73.0MViking Global Investors LP$48.3MMAK Capital One LLC$23.7MVanguard Group$22.1MLong Focus Capital Management, LLC$19.3MVanguard Capital Management LLC$10.1MBlackRock$6.8MNeuberger Berman Group LLC$4.0MQube Research & Technologies$4.0MHollow Brook Wealth Management LLC$3.9M

Largest holders (13F)

FundSharesValueChangeQuarter
Casdin Capital, LLC88,783,856$73.0Munchanged2026-06-30
Viking Global Investors LP58,651,170$48.3Munchanged2026-06-30
MAK Capital One LLC28,813,904$23.7Mincrease2026-06-30
Vanguard Group17,297,599$22.1Mincrease2025-12-31
Long Focus Capital Management, LLC23,500,000$19.3Mincrease2026-06-30
Vanguard Capital Management LLC12,252,998$10.1Mdecrease2026-06-30
BlackRock8,254,443$6.8Mdecrease2026-06-30
Neuberger Berman Group LLC4,958,620$4.0Mincrease2026-06-30
Qube Research & Technologies4,820,463$4.0Mincrease2026-06-30
Hollow Brook Wealth Management LLC5,200,829$3.9Mdecrease2026-09-30
Royce & Associates LP4,525,333$3.7Mincrease2026-06-30
Geode Capital Management, LLC3,896,574$3.2Mdecrease2026-06-30
Tikvah Management LLC3,551,058$2.9Mdecrease2026-06-30
Millennium Management LLC3,512,665$2.9Mincrease2026-06-30
Morgan Stanley2,831,668$2.3Mdecrease2026-06-30

Standard Biotools' latest quarter

Standard Biotools, Q3 2026: revenue $19.4M (-0.9% year over year), operating margin -102.0%, net earnings $13.5M, operating cash flow −$6.2M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most LAB stock?

By the latest 13F filings: Casdin Capital, LLC ($73.0M); Viking Global Investors LP ($48.3M); MAK Capital One LLC ($23.7M); Vanguard Group ($22.1M); Long Focus Capital Management, LLC ($19.3M).

What is the short interest in LAB?

2,445,793 shares were sold short at the 2026-10-15 settlement, -2.97% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.